Q1 2020 Spero Therapeutics Inc Earnings Call Transcript
Thank you for standing by. This is the conference operator. Welcome to the Spero Therapeutics First Quarter 2020 Earnings Conference Call and Corporate Update. (Operator Instructions) The conference is being recorded. (Operator Instructions)
I would now like to turn the conference over to Sharon Klahre, VP of IR and Strategy, please go ahead.
Great. Thank you, operator, and thank you all for participating in today's conference call. Earlier today, Spero Therapeutics released financial results and provided a pipeline review for the first quarter ended March 31, 2020. If you have yet to see the press release, it's available on the Investor page of the Spero Therapeutics website.
Before we begin, I'd like to remind you that some of the information contained in the news release and on this conference call contain forward-looking statements based on our current expectations. Such forward-looking statements are not a guarantee of performance, and the company's actual results could
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |